Narrow search
Showing 1 - 3 of 3
Cover Image
Patient relevant endpoints in oncology: Current issues in the context of early benefit assessment in Germany
Dabisch, Inna; Dethling, Jürgen; Dintsios, … - In: Health Economics Review 4 (2014) 2, pp. 1-8
The German AMNOG healthcare reform includes a mandatory early-benefit-assessment (EBA) at launch. As per German social code, EBA is based on registration trials and includes evaluation of the patient-relevant effect of the new medicines compared to an appropriate comparator as defined by the...
Persistent link: https://www.econbiz.de/10011599811
Cover Image
Patient relevant endpoints in oncology : current issues in the context of early benefit assessment in Germany
Dabisch, Inna; Dethling, Jürgen; Dintsios, … - In: Health economics review 4 (2014) 2, pp. 1-8
The German AMNOG healthcare reform includes a mandatory early-benefit-assessment (EBA) at launch. As per German social code, EBA is based on registration trials and includes evaluation of the patient-relevant effect of the new medicines compared to an appropriate comparator as defined by the...
Persistent link: https://www.econbiz.de/10010528451
Cover Image
Patient relevant endpoints in oncology: current issues in the context of early benefit assessment in Germany
Dabisch, Inna; Dethling, Jürgen; Dintsios, … - In: Health Economics Review 4 (2014) 1, pp. 1-8
D61; H51; I18. </AbstractSection> Copyright Dabisch et al.; licensee Springer. 2014
Persistent link: https://www.econbiz.de/10010998823